Sotera Health (NASDAQ:SHC) Shares Acquired by SG Americas Securities LLC

SG Americas Securities LLC grew its holdings in Sotera Health (NASDAQ:SHC - Free Report) by 271.6% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 36,364 shares of the company's stock after purchasing an additional 26,577 shares during the period. SG Americas Securities LLC's holdings in Sotera Health were worth $497,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors have also made changes to their positions in the stock. Oak Thistle LLC acquired a new position in shares of Sotera Health in the fourth quarter worth $222,000. Wealth Enhancement Advisory Services LLC increased its holdings in Sotera Health by 2.1% during the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 51,940 shares of the company's stock worth $711,000 after purchasing an additional 1,047 shares during the period. GAMMA Investing LLC raised its position in Sotera Health by 37.5% in the 4th quarter. GAMMA Investing LLC now owns 4,109 shares of the company's stock valued at $56,000 after purchasing an additional 1,121 shares in the last quarter. Retirement Systems of Alabama boosted its stake in shares of Sotera Health by 20.8% in the 3rd quarter. Retirement Systems of Alabama now owns 185,779 shares of the company's stock valued at $3,103,000 after buying an additional 32,051 shares during the period. Finally, Sanctuary Advisors LLC grew its position in shares of Sotera Health by 154.4% during the third quarter. Sanctuary Advisors LLC now owns 29,088 shares of the company's stock worth $486,000 after buying an additional 17,652 shares in the last quarter. 91.03% of the stock is currently owned by institutional investors and hedge funds.

Sotera Health Stock Performance

Shares of Sotera Health stock traded up $0.03 on Wednesday, reaching $13.84. 719,108 shares of the stock were exchanged, compared to its average volume of 885,783. The firm has a market capitalization of $3.92 billion, a PE ratio of 55.36 and a beta of 1.91. Sotera Health has a 1-year low of $10.71 and a 1-year high of $17.44. The business has a fifty day moving average price of $13.34 and a two-hundred day moving average price of $14.57. The company has a current ratio of 2.88, a quick ratio of 2.61 and a debt-to-equity ratio of 4.91.

Sotera Health (NASDAQ:SHC - Get Free Report) last issued its earnings results on Tuesday, November 5th. The company reported $0.17 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.18 by ($0.01). Sotera Health had a return on equity of 42.27% and a net margin of 6.31%. The business had revenue of $285.47 million for the quarter, compared to analysts' expectations of $278.64 million. During the same period last year, the company posted $0.18 earnings per share. The business's quarterly revenue was up 8.5% on a year-over-year basis. As a group, research analysts anticipate that Sotera Health will post 0.61 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several research firms have commented on SHC. The Goldman Sachs Group started coverage on shares of Sotera Health in a report on Friday, December 6th. They set a "neutral" rating and a $14.00 price target for the company. Royal Bank of Canada reiterated an "outperform" rating and issued a $17.00 price target on shares of Sotera Health in a research report on Thursday, November 21st. Finally, Citigroup increased their target price on shares of Sotera Health from $18.00 to $20.00 and gave the stock a "buy" rating in a research note on Wednesday, November 6th. Three investment analysts have rated the stock with a hold rating and four have issued a buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average target price of $16.08.

Sotera Health Company Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.